Literature DB >> 1618489

Mutation analysis and prenatal diagnosis in a Lesch-Nyhan family showing non-random X-inactivation interfering with carrier detection tests.

S Marcus1, A M Steen, B Andersson, B Lambert, U Kristoffersson, U Francke.   

Abstract

A nonsense mutation at the CpG-site in the codon for Arg(169) in the gene for hypoxanthine phosphoribosyltransferase (hprt) was identified by genomic polymerase chain reaction (PCR) and DNA sequencing in cultured fibroblasts from two brothers with Lesch Nyhan's syndrome. The recurrence of mutation at this CpG-site in several unrelated Lesch-Nyhan families suggests that deamination of 5-methylcytosine is a possible mechanism for mutagenesis. The level of hprt-mRNA in the fibroblasts of the patients was similar to that in healthy controls, whereas hprt-enzyme activity was not detectable. The mutation in this family was also identified in five female relatives and prenatally in a male fetus. Unexpectedly, results from hair follicle analyses and fibroblast selection studies in 8-azaguanine and 6-thioguanine medium showed a non-carrier phenotype in three of the female heterozygotes, whereas X-inactivation mosaicism was demonstrated in one heterozygote. A possible explanation for the apparent non-random X-inactivation in this family is the co-existence of the hprt mutation with an undefined X-linked lethal mutation. This observation is of practical relevance for carrier detection in other Lesch-Nyhan families.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618489     DOI: 10.1007/bf00194310

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Lesch-Nyhan syndrome: preventive control by prenatal diagnosis.

Authors:  J A Boyle; K O Raivio; K H Astrin; J D Schulman; M L Graf; J E Seegmiller; C B Jacobsen
Journal:  Science       Date:  1970-08-14       Impact factor: 47.728

2.  Levels of hypoxanthine phosphoribosyltransferase RNA in human cells.

Authors:  A M Steen; H Luthman; D Hellgren; B Lambert
Journal:  Exp Cell Res       Date:  1990-02       Impact factor: 3.905

3.  The fragile X mutation does not have any major effect on the expression of the hypoxanthine phosphoribosyltransferase (HPRT) locus in human fibroblasts.

Authors:  A M Steen; S Marcus; S Sahlén; K B Nielsen; B Lambert
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

4.  The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease.

Authors:  U Francke; J Felsenstein; S M Gartler; B R Migeon; J Dancis; J E Seegmiller; F Bakay; W L Nyhan
Journal:  Am J Hum Genet       Date:  1976-03       Impact factor: 11.025

5.  Cloned cDNA sequences of the hypoxanthine/guanine phosphoribosyltransferase gene from a mouse neuroblastoma cell line found to have amplified genomic sequences.

Authors:  J Brennand; A C Chinault; D S Konecki; D W Melton; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  A pitfall in the prenatal diagnosis of Lesch-Nyhan syndrome by chorionic villus sampling.

Authors:  T Page; R L Broock
Journal:  Prenat Diagn       Date:  1990-03       Impact factor: 3.050

7.  Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families.

Authors:  R A Gibbs; P N Nguyen; A Edwards; A B Civitello; C T Caskey
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

8.  Molecular evidence for new mutation at the hprt locus in Lesch-Nyhan patients.

Authors:  T P Yang; P I Patel; A C Chinault; J T Stout; L G Jackson; B M Hildebrand; C T Caskey
Journal:  Nature       Date:  1984 Aug 2-8       Impact factor: 49.962

9.  Hypoxanthine guanine phosphoribosyltransferase deficiency: nucleotide substitution causing Lesch-Nyhan syndrome identified for the first time among Japanese.

Authors:  S Fujimori; N Kamatani; Y Nishida; N Ogasawara; I Akaoka
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

10.  Genetic basis of hypoxanthine guanine phosphoribosyltransferase deficiency in a patient with the Lesch-Nyhan syndrome (HPRTFlint).

Authors:  B L Davidson; M Pashmforoush; W N Kelley; T D Palella
Journal:  Gene       Date:  1988-03-31       Impact factor: 3.688

View more
  2 in total

1.  Real-time PCR and linkage studies to identify carriers presenting HPRT deleted gene.

Authors:  Cristina Lapucci; Diego Pomarè Montin; Massimo Pandolfo; Matteo Bertelli
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

Review 2.  Genetic control of X inactivation and processes leading to X-inactivation skewing.

Authors:  J W Belmont
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.